Fadi Issa Profile
Fadi Issa

@fgissa

Followers
547
Following
1K
Media
10
Statuses
193

United Kingdom
Joined January 2009
Don't wanna be here? Send us removal request.
@fgissa
Fadi Issa
1 month
RT @IndiaSoTx: Meet the editor Fadi Issa at ISOT 2025 Jaipur! 🌟 @TransplantJrnl's @fgissa & @trig_oxford join @ttsorg for groundbreaking di….
0
7
0
@fgissa
Fadi Issa
4 months
RT @NDSurgicalSci: Congratulations to @fgissa who has been appointed as our new Professor of Transplantation at the Nuffield Department of….
0
4
0
@fgissa
Fadi Issa
4 months
RT @trig_oxford: Tumor-infiltrating lymphocyte scoring improves progression risk prediction in stage II melanoma: A retrospective cohort st….
Tweet card summary image
jaad.org
The American Joint Committee on Cancer eighth edition substaging might be suboptimal for predicting melanoma progression. Using it to select stage II patients for adjuvant immunotherapy risks...
0
1
0
@fgissa
Fadi Issa
7 months
RT @TXPDirect: The January issue of.@TXPDirect. is jam-packed with useful information for our diverse international transplantation readers….
0
3
0
@fgissa
Fadi Issa
8 months
RT @trig_oxford: "Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants.".h….
0
1
0
@fgissa
Fadi Issa
8 months
A big thank you to our patients, co-authors and collaborators for making this work possible @NDSurgicalSci @olivermccallion @trig_oxford.
0
0
2
@fgissa
Fadi Issa
8 months
Why does this matter?.💡 Treg therapy offers a pathway to reduce reliance on lifelong immunosuppression in kidney transplants. 💡 Our findings highlight the potential for local immune regulation within the graft, paving the way for safer and more effective treatments.
1
0
2
@fgissa
Fadi Issa
8 months
Key findings:.1️⃣ Treg-treated kidney transplant patients showed excellent long-term outcomes with no rejection episodes over 7 years. 2️⃣ Distinct immune infiltrates were observed, enriched with regulatory genes like IL10, PD-L1, and TIGIT, and a significant presence of B cells.
1
0
0
@fgissa
Fadi Issa
8 months
🚨New! 🚨 Our new paper is now out in @MedCellPress . Discover how clinical Treg therapy shapes immune responses in transplants.
1
5
11
@fgissa
Fadi Issa
11 months
RT @ttsorg: On behalf of TTS and MESOT, we would like to extend our heartfelt thanks to those who attended #TTS2024 in Istanbul and virtual….
0
5
0
@fgissa
Fadi Issa
11 months
RT @drvivekkute: ⁠ Expert insights! @ElmiMuller shares latest on Once-Daily Tacrolimus at #ISOT2024 Masterclass. #TransplantMedicine@Indi….
0
6
0
@fgissa
Fadi Issa
11 months
RT @TheLancet: Only 10% of global transplant demand is being met, according to the Global Observatory on Donation and Transplantation. On….
0
78
0
@fgissa
Fadi Issa
11 months
RT @quanyao: Very pleased to share our review presenting the latest literature on regulatory cell therapy for #kidney #transplantation, #gl….
0
1
0
@fgissa
Fadi Issa
11 months
RT @trig_oxford: Is there a role for regulatory cell therapy in autoimmune kidney disease? See below for a review of the current literature….
0
1
0
@fgissa
Fadi Issa
11 months
RT @drvivekkute: Global thought leaders, one platform! #TTS2024 offers unparalleled opportunities for collaboration & knowledge sharing. #T….
0
1
0
@grok
Grok
6 days
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
398
661
3K
@fgissa
Fadi Issa
11 months
RT @UHNTransplant: Congratulations🎉to Dr. Ana Konvalinka and her Post-doctoral Fellow Kieran Manion on winning the CST Mentor and Mentee Aw….
0
9
0
@fgissa
Fadi Issa
11 months
RT @ttsorg: We're proud to honor the #TTS2024 winners of the prestigious 2024 Medawar Prize, the highest honor bestowed by the society for….
0
7
0
@fgissa
Fadi Issa
11 months
RT @LjwestWest: Bravo to all!.
0
1
0